We are live on ! Find out more
SYNB

Putnam BioRevolution ETF
SYNB

Delisted

SYNB was delisted on the 13th of November, 2025.

Back to rankings

4 hedge funds and large institutions have $3.56M invested in Putnam BioRevolution ETF in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

1.34% less ownership

Funds ownership: 71.96% → 70.62% (-1.3%)

7% less capital invested

Capital invested by funds: $3.83M → $3.56M (-$274K)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$59

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$71.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$3.5M – – –
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$59K -$71.4K -2,410 -53%
UBS Group
3
UBS Group
Switzerland
$364 +$59 +2 +18%
Osaic Holdings
4
Osaic Holdings
Arizona
$55 – – –

SYNB Hedge Fund Activity: Q1 2025 in Review

4 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q1 2025, worth a combined $3.56M — down 7.2% from $3.83M a quarter earlier.

Fund positioning in SYNB was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $59. The largest seller was Royal Bank of Canada, cutting an estimated $71.4K.

  • 4 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $3.56M of Putnam BioRevolution ETF stock for Q1 2025, down 7.2% quarter-over-quarter.
  • 0 funds opened new Putnam BioRevolution ETF positions in Q1 2025 and 0 closed out.
  • The largest Putnam BioRevolution ETF buyer in Q1 2025 was UBS Group, an estimated $59 added.
  • The largest Putnam BioRevolution ETF seller in Q1 2025 was Royal Bank of Canada, an estimated $71.4K sold.

Based on aggregated 13F filings for Q1 2025.